{"ticker": {"uuid": "494d8676-2cc6-4860-bdb4-37e9e4702e1f", "symbol": "HIMS", "name": "Hims Hers Health Inc", "exchange": "NYSE", "country": "US", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Hims & Hers Health Jumps 6.2% After B of A Securities Maintains Neutral", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPamVxaEhsNEF6VGxXZVdBZHRYYnZCbXVFZlNtZnhOM1I3WXlMdjA3ektUekwwSEpXeWZqczRCdkpzbmVjY29FdTVBTVQyaDNuRFplWS1uTWNQN1pMR19fdzVhdDNKa1JqQXpEdVJBNVBxUzFmLXRJdmxxeFk1VmlXRmtZZjdJZnJQS0NBdG9wemV1Q0RReXB5cklFMk4wRVHSAZ8BQVVfeXFMT2plcWhIbDRBelRsV2VXQWR0WGJ2Qm11RWZTbWZ4TjNSN1l5THYwN3pLVHpMMEhKV3lmanM0QnZKc25lY2NvRXU1QU1UMmgzbkRaZVktbk1jUDdaTEdfX3c1YXQzSmtSakF6RHVSQTVQcVMxZi10SXZscXhZNVZpV0ZrWWY3SWZyUEtDQXRvcHpldUNEUXlweXJJRTJOMEVR?oc=5", "source_name": "AlphaStreet", "published_at": "2026-07-15T23:34:40+00:00", "published_display": "15 Jul 2026 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look at Hims & Hers Health Inc (HIMS) After 5.8% Gain -- GF Va", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQelgtb3FRWVBNVldEX3VQUGR2S21hNzUzRlBjdjgwNlctZHJJanRNWDNBdm5lcFFRSGV2bUJZRHBrOFNkQXYxVDJfTktkWTVEN3hkSF9TZ0RuRFAxT0k4VnBBZXhkbHk5azQ4cUs1T2FSTk5Ra1V0M3B6TmRPWjBRN0hZX3hpcVNEbzZ6N2sxYUZ5Vy1pMThEUi1Vb0hHUEItNXRpZ0daT1RYRThsVnlCNU9senVaUjJqalhmZ09qWERrOGpoYnAw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T22:55:46+00:00", "published_display": "15 Jul 2026 22:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Hims & Hers Health's (HIMS) Peptide Push Amid FDA Scrutiny Has Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T00:17:36+00:00", "published_display": "15 Jul 2026 00:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/hims-hers-health-inc-hims-214503303.html", "source_name": "Zacks", "published_at": "2026-07-14T21:45:03+00:00", "published_display": "14 Jul 2026 21:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQTmFzT1g5LXFvWnJjVGJqNUJWRHNqVTE5M09tOXJib0pSSU54dUxucGlDdGRpOFlYWEctZ2VMV09iVWdienRWTFY1Z2J1bWRoZ09ZZi1pVGRCZFo5eHg2aWRIbGNGa0dVcnNVVEJSOWRLSlB1cVItMWJaU0xrUXpnTlkwR0FjZGh0SUI2RXluNTl4cWtQd25DZ290dnMxTkdHTUJ0cVFQM0JCck5waXFZ?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-14T01:49:35+00:00", "published_display": "14 Jul 2026 01:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers schedules Aug. 10 call on latest health platform results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTGtMWmN0RGdTbmNnT0VweDhoZ2xiN2dGQ0F5TVpSbDFuU2syQnUxZk9JeHZjb3RjZWFOTU5sRDJfNnJxdnJ1a1ZYSGw4Q0pXTDh6c0xsaTZRVWVYYVB6SHI1Mzl3OXpjLUdVX0lTR0V2UzIwTjA5S2xLOGZ4MDl4X3RLZm1zYVJ5Z0VlNHFVUGg3R1R3RWV0aC1obGxERGQzNmU2cXRQT1h2WDlqS3d2ai1MZVk2WTJ1?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:05:00+00:00", "published_display": "13 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/most-watched-stock-hims-hers-130003841.html", "source_name": "Zacks", "published_at": "2026-07-13T13:00:03+00:00", "published_display": "13 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health Stock (HIMS) Opinions on Recent Technical Breakouts and Growth Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNaGlyVDZteEYtWTByZU5VSEZNd3IwTzgtNzRJYVI2ZEY4UnZod2pSYkw0c2xyTURRUjU3RkoxV0d5TVhIalBKZ2xZRVpEdXkwSzRwQmlzTnlMOHgyN3VoUm8zZDFxdlJaMnFJb2FocDNrUUR4Vk45QnNFc1dtN19pMGh1by10UHNKS19HS3dPMDJ1MG9QNmNuM0NZRmhIUnlsdm9EVDMzdkU0alJxYVhHWV8wOXhmZVhHTEl4QlludEdYWmJxLWxYTmpB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-10T14:07:00+00:00", "published_display": "10 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Draws GLP 1 Attention, Is The Valuation Already Too Rich?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T19:23:23+00:00", "published_display": "09 Jul 2026 19:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-why-hims-hers-health-214504071.html", "source_name": "Zacks", "published_at": "2026-07-07T21:45:04+00:00", "published_display": "07 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Reactions to HIMS Trends in Macro Strategies", "summary": "This article analyzes Hims & Hers Health Inc. (NASDAQ: HIMS) using AI models to identify potential trading strategies. It highlights a strong near and mid-term positive sentiment, but a weak long-term outlook, and provides specific entry, target, and stop-loss levels for position", "url": "https://news.stocktradersdaily.com/news_release/38/Technical_Reactions_to_HIMS_Trends_in_Macro_Strategies_070726102001_1783477201.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-07T22:20:00", "published_display": "07 Jul 2026 22:20", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CFO Okupe sells $261k in stock", "summary": "Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold Class A Common Stock worth approximately $261,351 after exercising stock options. This transaction was part of a pre-arranged trading plan, and Okupe now directly holds 284,321 shares. The company has also seen positive analyst ", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cfo-okupe-sells-261k-in-stock-93CH-4780062", "source_name": "Investing.com", "published_at": "2026-07-07T21:09:49", "published_display": "07 Jul 2026 21:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CFO exercises options and sells 7,163 shares under 10b5-1 plan", "summary": "Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options for 7,163 shares at $5.01 per share and subsequently sold the same number of shares at an average price of $36.4863 per share. These transactions were carried out under a pre-established Rule 10b5-1 trading plan a", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-aa8964df03cb.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:09:49", "published_display": "07 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?", "summary": "", "url": "https://finance.yahoo.com/m/a67327b4-5c62-3c55-a3e0-8d48bee17a1d/hims-%26-hers-health-vs..html", "source_name": "Motley Fool", "published_at": "2026-07-07T01:05:13+00:00", "published_display": "07 Jul 2026 01:05", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Hims & Hers Health (HIMS) Is Up 8.4% After Securing a $400 Million JPMorgan Facility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T17:42:41+00:00", "published_display": "05 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - Recover Losses - Contact Levi & Korsinsky Before August 25, 2025", "summary": "A class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) alleging securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims Hims engaged in deceptive promotion of \"knockoff\" versions of Wegovy, risking termination of its collaboration wit", "url": "https://www.natlawreview.com/press-releases/class-action-lawsuit-filed-against-hims-hers-health-inc-hims-recover-losses", "source_name": "The National Law Review", "published_at": "2026-07-01T01:38:57", "published_display": "01 Jul 2026 01:38", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Trade Ideas \u2014 SIX:HIMS.USD", "summary": "This article compiles various trade ideas and analyses for Hims & Hers Health, Inc. (HIMS) stock, covering different perspectives from bullish long-term outlooks to cautious short-term setups. Key themes include the company's strong June performance, expansion into new markets an", "url": "https://www.tradingview.com/symbols/SIX-HIMS.USD/ideas/", "source_name": "TradingView", "published_at": "2026-06-30T02:40:28", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQMWxNQm9DWGhocVFiLUd5TGVhUXl5RkhMUTM0bmFjNjdNbWxDSnRiSWpkZW9qMWNZRURLcHhsLU1Ta0VrR0otcEIxcmo4ZmMzcjF5WDczWXdOcUd0RWdXcVBtZ2xSMHh0Q2Y5WDBCd3pUeUNranVqTEd6a21KcHhfOVpsZUVyUFh2TGx5UlAzX1VDOHpm?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Shareholders of Securities Fraud Class Action Lawsuit Deadline", "summary": "Kessler Topaz Meltzer & Check, LLP has issued a reminder to shareholders of Hims & Hers Health, Inc. (HIMS) about an ongoing securities fraud class action lawsuit. Investors who purchased HIMS securities between April 29, 2025, and June 23, 2025, are affected, and the lead plaint", "url": "https://www.natlawreview.com/press-releases/hims-class-action-alert-kessler-topaz-meltzer-check-llp-reminds-hims-hers", "source_name": "The National Law Review", "published_at": "2026-06-28T01:09:26", "published_display": "28 Jun 2026 01:09", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025 - Contact Levi & Korsinsky", "summary": "Levi & Korsinsky, LLP has filed a class action securities lawsuit against Hims & Hers Health, Inc. (NYSE:HIMS) for alleged securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims that Hims engaged in deceptive promotion of \"knockoff\" versions of Wegovy\u00ae, po", "url": "https://natlawreview.com/press-releases/lost-money-hims-hers-health-inc-hims-join-class-action-august-25-2025", "source_name": "The National Law Review", "published_at": "2026-06-27T14:40:28", "published_display": "27 Jun 2026 14:40", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading the Move, Not the Narrative: (HIMS) Edition", "summary": "This article provides an AI-generated analysis for Hims & Hers Health Inc. (NASDAQ: HIMS), highlighting weak near-term sentiment but mid-term strength within a long-term weak bias. It details three distinct institutional trading strategies\u2014Position Trading, Momentum Breakout, and", "url": "https://news.stocktradersdaily.com/news_release/40/Trading_the_Move,_Not_the_Narrative:_HIMS_Edition_062626091202_1782522722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-26T21:12:00", "published_display": "26 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Actuals & Estimates (NYSE:HIMS)", "summary": "This article provides an overview of Hims & Hers Health, Inc. (NYSE:HIMS) stock performance, financial actuals, and analyst estimates. It covers the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings dates. The content also in", "url": "https://www.tradingview.com/symbols/NYSE-HIMS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:18", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Hims & Hers Health, Inc. Class A \u2013 XETR:82W", "summary": "This article provides access to the \"Price to book forward\" financial metric for Hims & Hers Health, Inc. Class A (XETR:82W) on TradingView. It indicates that the market was closed at the time of publication and there were no trades. The content primarily directs users to various", "url": "https://www.tradingview.com/symbols/XETR-82W/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:40:17", "published_display": "25 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays Raises Price Target On Hims & Hers Health (NYSE: HIMS) As Weight Loss Business Drives Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNOVpjTldjeTYybnZ1bi1wU2pKNGFzX3RjajBOYmNVYTduS3VyTXpIMFZReFB3TnYySUcybFlkSHdFZmVSLWM3VHBjcGpOSnZ4eHpzS0JXaHhjWTF3MTRxcFowVm9odEZETHFNbnNHejMxMkR4OUJyM1IyVW9obzRNUkVhU3N3YXlIUnd2cjhab08wMm50eEFJRHhKRXFwbUhpZWhDeGVmYndYTVlZMFVOM201ZkhQXzY5ZFptazFqMVFUbGNNZXB5ZzZ3R21vUUVGalpnVVJSeDRldWlVNUxwTg?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-24T22:20:00+00:00", "published_display": "24 Jun 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CMO Patrick Carroll sells $830,410 in stock", "summary": "Patrick Carroll, CMO of Hims & Hers Health, Inc., sold 23,726 shares of company stock for $830,410 on June 18, 2026. This transaction reduced his direct holdings to 181,861 shares of Class A Common Stock. The sale follows other company developments, including a raised price targe", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cmo-patrick-carroll-sells-830410-in-stock-93CH-4756955", "source_name": "Investing.com", "published_at": "2026-06-24T09:41:13", "published_display": "24 Jun 2026 09:41", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays\u2019 Target Increase?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdGlLWTFJSThuaDJ5ZjBsVnh3c2RlNDk0czVORE1KWklybDF2UGN6eHNEWVNTTWtTNHhQOUpRdHhPdWZGM2U2YVNKM1BmazZvUUpoMTEyVVVUSzNmbl9acUhIb3hHcHAyUzJDY3FfekI4dnFBRWFjNjVmMllDZHN2RmFlc1FrbjFCSU1TbEwwSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Hims & Hers Health, Inc. Insider Trading Activity", "summary": "Hims & Hers Health, Inc. CFO Oluyemi Okupe reported stock option exercises and sales of common shares under a pre-arranged Rule 10b5-1 trading plan. Okupe exercised 6,376 shares of Class A common stock at $5.01 per share and sold 18,197 shares at an average price of $34.0285 per ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-215db3927dc2.html", "source_name": "Stock Titan", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CFO Oluyemi Okupe sells $619,216 in shares By Investing.com", "summary": "Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold 18,197 shares of Class A Common Stock for $619,216 on June 22, 2026, after exercising stock options. The sale was executed under a Rule 10b5-1 trading plan. This transaction follows other company developments, including a raised", "url": "https://ca.investing.com/news/stock-market-news/hims--hers-cfo-oluyemi-okupe-sells-619216-in-shares-93CH-4704395", "source_name": "Investing.com Canada", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CMO sells 23,726 shares, retains 181,861", "summary": "Hims & Hers Health, Inc.'s Chief Medical Officer, Patrick Harrison, sold 23,726 shares of Class A Common Stock at $35.00 per share in an open-market transaction. Following this sale, Harrison still directly holds 181,861 shares of the company. The transaction is categorized as a ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-7648d0703fd3.html", "source_name": "Stock Titan", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNQzEwUG1NVWZiVlg0SUgxM0dZZlgzS0lQQUhyS0VWUGlHUV9uUDQ2SVRocGpNQVk3MUUwU0F4ZUl2T2pabHdNdzVpS1ZJZ2ZzUnZtaEsxVlFVeGNmNUxESkpoMkZ2RHhqVmQyZHBVcW5MREtMNlJUSkZ3STQwdmkzUGhSOV9rT3h3XzYxVmhrVTJlQzRG?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOUzR4UVh4TzNkVS01RXQ1dDJDMk1tT0t6Q0J5WHFoWlRBX2pkUGd2S25xUHVHOVdrMTkyWHd6dHJ3LTVJMURaOTNsemdJQmRCbFJTcV9JT0V4cmxfYzYyR2ZsbURkeGZzdHZ0OW9IZlJZczUyRXlmTXloLUtQbzBBMWJvRy0ya0VtbXBtVWRkWl8zRHd4?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Trade Ideas \u2014 BIVA:HIMS", "summary": "This article compiles several trading ideas and analyses for Hims & Hers Health, Inc. (HIMS) from various traders on TradingView. It discusses potential technical patterns like inverse head and shoulders and mini head and shoulders, along with support and resistance levels, price", "url": "https://www.tradingview.com/symbols/BIVA-HIMS/ideas/page-14/", "source_name": "TradingView", "published_at": "2026-06-21T15:40:41", "published_display": "21 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers PAO Irene Becklund sells $370,518 in stock By Investing.com", "summary": "Irene Becklund, Principal Accounting Officer at Hims & Hers Health, Inc. (NASDAQ:HIMS), sold shares totaling $370,518 in two transactions on June 16 and June 17, 2026. These sales were part of a pre-arranged trading plan and followed the vesting of Restricted Stock Units. The com", "url": "https://ng.investing.com/news/insider-trading-news/hims--hers-pao-irene-becklund-sells-370518-in-stock-93CH-2564181", "source_name": "Investing.com Nigeria", "published_at": "2026-06-18T21:10:29", "published_display": "18 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CEO exercises RSUs and withholds shares for taxes", "summary": "Hims & Hers Health CEO Andrew Dudum exercised 154,991 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations related to this vesting, 85,632 shares were withheld by the company at $30.17 per share. Following these transactions, Dudum directly holds 957,043 share", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-b76d5da84006.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:09:21", "published_display": "18 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS (NYSE) Form 144: 12,500 and 11,226 vested Class A shares listed", "summary": "Hims & Hers Health, Inc. (HIMS) has filed a Form 144 indicating proposed sales related to the vesting of Class A shares. The filing specifies two vesting events: 12,500 shares on March 15, 2026, and 11,226 shares on June 15, 2026. Fidelity Brokerage Services LLC is named as the b", "url": "https://www.stocktitan.net/sec-filings/HIMS/144-hims-hers-health-inc-sec-filing-3ae98b82d05d.html", "source_name": "Stock Titan", "published_at": "2026-06-18T19:02:10", "published_display": "18 Jun 2026 19:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers PAO Irene Becklund sells $370,518 in stock", "summary": "Hims & Hers Health, Inc.'s Principal Accounting Officer, Irene Becklund, sold $370,518 worth of Class A Common Stock across two transactions in mid-June. These sales were executed under a pre-arranged trading plan, following the vesting of Restricted Stock Units. After these tran", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-pao-irene-becklund-sells-370518-in-stock-93CH-4748696", "source_name": "Investing.com", "published_at": "2026-06-18T09:09:39", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CTO Mohamed Elshenawy sells $946,260 in stock", "summary": "Hims & Hers Health, Inc. CTO Mohamed Elshenawy sold 30,040 shares of Class A Common Stock for $946,260 on June 17, 2026, as part of a Rule 10b5-1 trading plan. He also disposed of 151,534 shares worth $4,571,780 to cover tax obligations related to vested Restricted Stock Units (R", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cto-mohamed-elshenawy-sells-946260-in-stock-93CH-4748697", "source_name": "Investing.com", "published_at": "2026-06-18T08:40:00", "published_display": "18 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers COO Michael Chi sells $441,850 in company stock", "summary": "Michael Chi, COO of Hims & Hers Health, Inc., sold 14,027 shares of company stock worth $441,850 on June 17, 2026, under a pre-arranged trading plan. This sale followed his acquisition of 86,264 shares through RSU vesting, with a portion withheld for taxes. The company has also s", "url": "https://m.uk.investing.com/news/insider-trading-news/hims--hers-coo-michael-chi-sells-441850-in-company-stock-93CH-4734275?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-18T03:10:39", "published_display": "18 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (HIMS) exec nets shares after 32,919 RSU conversion", "summary": "Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor converted 32,919 Restricted Stock Units (RSUs) into Class A Common shares on June 15, 2026. After withholding 15,396 shares for tax obligations at $30.17 per share, she now directly holds 48,961 Class A Common shares.", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-4a5e47ce0d77.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (HIMS) CMO logs RSU vesting and tax share withholding", "summary": "Hims & Hers Health Chief Medical Officer Patrick Harrison reported the vesting of 25,926 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations, 8,310 shares were withheld by the company, meaning no open-market sale occurred. Following these transactions, Harris", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-c1fcb1d7f2d8.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) COO sells 14,027 shares, holds 432,124", "summary": "Hims & Hers Health, Inc. COO Michael Chi sold 14,027 shares of Class A Common Stock at $31.50 per share under a pre-arranged Rule 10b5-1 trading plan. This transaction followed the exercise of 86,264 RSU awards and the withholding of 47,699 shares to cover tax obligations. After ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-2e81171f010e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) CTO exercises awards and sells 30,040 shares", "summary": "Hims & Hers Health's CTO, Mohamed Elshenawy, exercised derivative awards for 282,597 shares and sold 30,040 shares at $31.50 each under a pre-arranged Rule 10b5-1 trading plan. The company also withheld 151,534 shares to cover tax obligations from RSU vesting. Following these tra", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-798b51647b8e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lead Independent Director of Hims & Hers Health David Wells Buys 27% More Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what i", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Margins Worsen As Q1 Loss Resurfaces And Tests Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOTWpnQnVoeGNteURwcEVKNkQ0TUNlemg1SEFRRUkwMVdrdUF3ajhIU2pweGRYaVd1S2hxaE1LdlJXV2JZVzh6MnRKVWpIM2ZHMGtMMUdncWRGMzEyYjFTeVVxeEhNdjdCWWRva21xaGhxbjRhdkFxV1pyWkt5ZUk3TGt1R3ZPLTRRcE0zSDZQaU90ZmdTd3ZvcmJ0NFI?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Hims & Hers Health (HIMS) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPTG5UQ2d6a0xaX0YzUzNNRVJ3UmtRbUsyTjNiQ3Z1NldRbWhpSXk1cEw4QXBDUHRTNEhMUTM5cXRJYjNRd3V5NWp0RmhnM0ZfWHVEaTJXSGMyWFFLaHpvNVljOFNCRjdpM0NLY0FWREVSUFRqZ0pPSy1rMkZrTDloWlY4YkhZTENvaU5VWExNamhvT3kx?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Hims & Hers Health (HIMS) Pricing Reflect Fast-Growing Telehealth Hype Or Business Fundamentals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQenJ0SlI0Qi1FWUlBa2ZIdm5ZN0piTkpwS1p6VWlTeE5aVGdRMHJnRTUtdzh2ZXhkNWhEdUtJMUxDS2oyOFZQeXJVT1RSVU9sRWhjaWJBVmxKUnZ4cm85ZS05WnNXZDYxVVNuSWJNM1RucVZxUkFiXzRSZWNCaDJQZk56LVhteGpBNDZYdXpLS043amZkcG5nRjZoUEw3Qk9xU0xMTHN2VzdqamV1SU10cUJtc3N5NWNISi1mem9fYTQxX0NTMlpKdW01dFdpRHJvWDRtUzNhU1U1N3JqUHZENzhYZkdnMlBmeHVsNGdMa29icmF6UnlRQnVXX1haY3N2?oc=5", "source_name": "TradingView", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNOEQ3d0FVcEtzdXpCSlBaSGhzT1FrNlhtWm5qQ2loWjVjTkdmckNJcktybXd3Y0hiZENOaGRYSzNvM2JmSHVzdkdYSGxaWS1nNWh0NDI5Z3dzZV92bVJwMTkyTEZzcWhQb2pmUG9KWVhrMmczaFpaRklmYVlQLVlVRVhVZXhQN1JXNkdjUU85dDBXQ045aEVzYXI0LVFYX292cE1HbEVIVEpteWNvNV9ZU21wNno?oc=5", "source_name": "Reuters", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Price Is Right For Hims & Hers Health, Inc. (NYSE:HIMS) Even After Diving 46%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Hims & Hers Health Jumps 6.2% After B of A Securities Maintains Neutral", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPamVxaEhsNEF6VGxXZVdBZHRYYnZCbXVFZlNtZnhOM1I3WXlMdjA3ektUekwwSEpXeWZqczRCdkpzbmVjY29FdTVBTVQyaDNuRFplWS1uTWNQN1pMR19fdzVhdDNKa1JqQXpEdVJBNVBxUzFmLXRJdmxxeFk1VmlXRmtZZjdJZnJQS0NBdG9wemV1Q0RReXB5cklFMk4wRVHSAZ8BQVVfeXFMT2plcWhIbDRBelRsV2VXQWR0WGJ2Qm11RWZTbWZ4TjNSN1l5THYwN3pLVHpMMEhKV3lmanM0QnZKc25lY2NvRXU1QU1UMmgzbkRaZVktbk1jUDdaTEdfX3c1YXQzSmtSakF6RHVSQTVQcVMxZi10SXZscXhZNVZpV0ZrWWY3SWZyUEtDQXRvcHpldUNEUXlweXJJRTJOMEVR?oc=5", "source_name": "AlphaStreet", "published_at": "2026-07-15T23:34:40+00:00", "published_display": "15 Jul 2026 23:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look at Hims & Hers Health Inc (HIMS) After 5.8% Gain -- GF Va", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxQelgtb3FRWVBNVldEX3VQUGR2S21hNzUzRlBjdjgwNlctZHJJanRNWDNBdm5lcFFRSGV2bUJZRHBrOFNkQXYxVDJfTktkWTVEN3hkSF9TZ0RuRFAxT0k4VnBBZXhkbHk5azQ4cUs1T2FSTk5Ra1V0M3B6TmRPWjBRN0hZX3hpcVNEbzZ6N2sxYUZ5Vy1pMThEUi1Vb0hHUEItNXRpZ0daT1RYRThsVnlCNU9senVaUjJqalhmZ09qWERrOGpoYnAw?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-15T22:55:46+00:00", "published_display": "15 Jul 2026 22:55", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Hims & Hers Health's (HIMS) Peptide Push Amid FDA Scrutiny Has Changed Its Investment Story", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-15T00:17:36+00:00", "published_display": "15 Jul 2026 00:17", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Outpaces Stock Market Gains: What You Should Know", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/hims-hers-health-inc-hims-214503303.html", "source_name": "Zacks", "published_at": "2026-07-14T21:45:03+00:00", "published_display": "14 Jul 2026 21:45", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS Stock Eyes Breakout Week: Eight New Partners Fuel Push To Build An All-In-One Health Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQTmFzT1g5LXFvWnJjVGJqNUJWRHNqVTE5M09tOXJib0pSSU54dUxucGlDdGRpOFlYWEctZ2VMV09iVWdienRWTFY1Z2J1bWRoZ09ZZi1pVGRCZFo5eHg2aWRIbGNGa0dVcnNVVEJSOWRLSlB1cVItMWJaU0xrUXpnTlkwR0FjZGh0SUI2RXluNTl4cWtQd25DZ290dnMxTkdHTUJ0cVFQM0JCck5waXFZ?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-14T01:49:35+00:00", "published_display": "14 Jul 2026 01:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers schedules Aug. 10 call on latest health platform results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQTGtMWmN0RGdTbmNnT0VweDhoZ2xiN2dGQ0F5TVpSbDFuU2syQnUxZk9JeHZjb3RjZWFOTU5sRDJfNnJxdnJ1a1ZYSGw4Q0pXTDh6c0xsaTZRVWVYYVB6SHI1Mzl3OXpjLUdVX0lTR0V2UzIwTjA5S2xLOGZ4MDl4X3RLZm1zYVJ5Z0VlNHFVUGg3R1R3RWV0aC1obGxERGQzNmU2cXRQT1h2WDlqS3d2ai1MZVk2WTJ1?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:05:00+00:00", "published_display": "13 Jul 2026 20:05", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/most-watched-stock-hims-hers-130003841.html", "source_name": "Zacks", "published_at": "2026-07-13T13:00:03+00:00", "published_display": "13 Jul 2026 13:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health Stock (HIMS) Opinions on Recent Technical Breakouts and Growth Prospects", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxNaGlyVDZteEYtWTByZU5VSEZNd3IwTzgtNzRJYVI2ZEY4UnZod2pSYkw0c2xyTURRUjU3RkoxV0d5TVhIalBKZ2xZRVpEdXkwSzRwQmlzTnlMOHgyN3VoUm8zZDFxdlJaMnFJb2FocDNrUUR4Vk45QnNFc1dtN19pMGh1by10UHNKS19HS3dPMDJ1MG9QNmNuM0NZRmhIUnlsdm9EVDMzdkU0alJxYVhHWV8wOXhmZVhHTEl4QlludEdYWmJxLWxYTmpB?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-07-10T14:07:00+00:00", "published_display": "10 Jul 2026 14:07", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Draws GLP 1 Attention, Is The Valuation Already Too Rich?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-09T19:23:23+00:00", "published_display": "09 Jul 2026 19:23", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Here's Why Hims & Hers Health, Inc. (HIMS) Fell More Than Broader Market", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/heres-why-hims-hers-health-214504071.html", "source_name": "Zacks", "published_at": "2026-07-07T21:45:04+00:00", "published_display": "07 Jul 2026 21:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Technical Reactions to HIMS Trends in Macro Strategies", "summary": "This article analyzes Hims & Hers Health Inc. (NASDAQ: HIMS) using AI models to identify potential trading strategies. It highlights a strong near and mid-term positive sentiment, but a weak long-term outlook, and provides specific entry, target, and stop-loss levels for position", "url": "https://news.stocktradersdaily.com/news_release/38/Technical_Reactions_to_HIMS_Trends_in_Macro_Strategies_070726102001_1783477201.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-07T22:20:00", "published_display": "07 Jul 2026 22:20", "sentiment": "negative", "sentiment_pct": 38, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CFO Okupe sells $261k in stock", "summary": "Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold Class A Common Stock worth approximately $261,351 after exercising stock options. This transaction was part of a pre-arranged trading plan, and Okupe now directly holds 284,321 shares. The company has also seen positive analyst ", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cfo-okupe-sells-261k-in-stock-93CH-4780062", "source_name": "Investing.com", "published_at": "2026-07-07T21:09:49", "published_display": "07 Jul 2026 21:09", "sentiment": "negative", "sentiment_pct": 41, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CFO exercises options and sells 7,163 shares under 10b5-1 plan", "summary": "Hims & Hers Health, Inc. CFO Oluyemi Okupe exercised stock options for 7,163 shares at $5.01 per share and subsequently sold the same number of shares at an average price of $36.4863 per share. These transactions were carried out under a pre-established Rule 10b5-1 trading plan a", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-aa8964df03cb.html", "source_name": "Stock Titan", "published_at": "2026-07-07T20:09:49", "published_display": "07 Jul 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health vs. Teladoc Health: Which Healthcare Stock Is a Better Buy in 2026?", "summary": "", "url": "https://finance.yahoo.com/m/a67327b4-5c62-3c55-a3e0-8d48bee17a1d/hims-%26-hers-health-vs..html", "source_name": "Motley Fool", "published_at": "2026-07-07T01:05:13+00:00", "published_display": "07 Jul 2026 01:05", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Hims & Hers Health (HIMS) Is Up 8.4% After Securing a $400 Million JPMorgan Facility", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-07-05T17:42:41+00:00", "published_display": "05 Jul 2026 17:42", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Class Action Lawsuit Filed Against Hims & Hers Health, Inc. (HIMS) - Recover Losses - Contact Levi & Korsinsky Before August 25, 2025", "summary": "A class action lawsuit has been filed against Hims & Hers Health, Inc. (HIMS) alleging securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims Hims engaged in deceptive promotion of \"knockoff\" versions of Wegovy, risking termination of its collaboration wit", "url": "https://www.natlawreview.com/press-releases/class-action-lawsuit-filed-against-hims-hers-health-inc-hims-recover-losses", "source_name": "The National Law Review", "published_at": "2026-07-01T01:38:57", "published_display": "01 Jul 2026 01:38", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Trade Ideas \u2014 SIX:HIMS.USD", "summary": "This article compiles various trade ideas and analyses for Hims & Hers Health, Inc. (HIMS) stock, covering different perspectives from bullish long-term outlooks to cautious short-term setups. Key themes include the company's strong June performance, expansion into new markets an", "url": "https://www.tradingview.com/symbols/SIX-HIMS.USD/ideas/", "source_name": "TradingView", "published_at": "2026-06-30T02:40:28", "published_display": "30 Jun 2026 02:40", "sentiment": "positive", "sentiment_pct": 68, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Stock Falls Amid Market Uptick: What Investors Need to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxQMWxNQm9DWGhocVFiLUd5TGVhUXl5RkhMUTM0bmFjNjdNbWxDSnRiSWpkZW9qMWNZRURLcHhsLU1Ta0VrR0otcEIxcmo4ZmMzcjF5WDczWXdOcUd0RWdXcVBtZ2xSMHh0Q2Y5WDBCd3pUeUNranVqTEd6a21KcHhfOVpsZUVyUFh2TGx5UlAzX1VDOHpm?oc=5", "source_name": "Market source", "published_at": "2026-06-29T07:00:00+00:00", "published_display": "29 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 22, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS Class Action Alert: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Shareholders of Securities Fraud Class Action Lawsuit Deadline", "summary": "Kessler Topaz Meltzer & Check, LLP has issued a reminder to shareholders of Hims & Hers Health, Inc. (HIMS) about an ongoing securities fraud class action lawsuit. Investors who purchased HIMS securities between April 29, 2025, and June 23, 2025, are affected, and the lead plaint", "url": "https://www.natlawreview.com/press-releases/hims-class-action-alert-kessler-topaz-meltzer-check-llp-reminds-hims-hers", "source_name": "The National Law Review", "published_at": "2026-06-28T01:09:26", "published_display": "28 Jun 2026 01:09", "sentiment": "negative", "sentiment_pct": 28, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lost Money on Hims & Hers Health, Inc. (HIMS)? Join Class Action Before August 25, 2025 - Contact Levi & Korsinsky", "summary": "Levi & Korsinsky, LLP has filed a class action securities lawsuit against Hims & Hers Health, Inc. (NYSE:HIMS) for alleged securities fraud between April 29, 2025, and June 23, 2025. The lawsuit claims that Hims engaged in deceptive promotion of \"knockoff\" versions of Wegovy\u00ae, po", "url": "https://natlawreview.com/press-releases/lost-money-hims-hers-health-inc-hims-join-class-action-august-25-2025", "source_name": "The National Law Review", "published_at": "2026-06-27T14:40:28", "published_display": "27 Jun 2026 14:40", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading the Move, Not the Narrative: (HIMS) Edition", "summary": "This article provides an AI-generated analysis for Hims & Hers Health Inc. (NASDAQ: HIMS), highlighting weak near-term sentiment but mid-term strength within a long-term weak bias. It details three distinct institutional trading strategies\u2014Position Trading, Momentum Breakout, and", "url": "https://news.stocktradersdaily.com/news_release/40/Trading_the_Move,_Not_the_Narrative:_HIMS_Edition_062626091202_1782522722.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-26T21:12:00", "published_display": "26 Jun 2026 21:12", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Actuals & Estimates (NYSE:HIMS)", "summary": "This article provides an overview of Hims & Hers Health, Inc. (NYSE:HIMS) stock performance, financial actuals, and analyst estimates. It covers the current stock price, historical highs and lows, market capitalization, volatility, and upcoming earnings dates. The content also in", "url": "https://www.tradingview.com/symbols/NYSE-HIMS/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T06:40:18", "published_display": "26 Jun 2026 06:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Hims & Hers Health, Inc. Class A \u2013 XETR:82W", "summary": "This article provides access to the \"Price to book forward\" financial metric for Hims & Hers Health, Inc. Class A (XETR:82W) on TradingView. It indicates that the market was closed at the time of publication and there were no trades. The content primarily directs users to various", "url": "https://www.tradingview.com/symbols/XETR-82W/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-25T21:40:17", "published_display": "25 Jun 2026 21:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Barclays Raises Price Target On Hims & Hers Health (NYSE: HIMS) As Weight Loss Business Drives Momentum", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxNOVpjTldjeTYybnZ1bi1wU2pKNGFzX3RjajBOYmNVYTduS3VyTXpIMFZReFB3TnYySUcybFlkSHdFZmVSLWM3VHBjcGpOSnZ4eHpzS0JXaHhjWTF3MTRxcFowVm9odEZETHFNbnNHejMxMkR4OUJyM1IyVW9obzRNUkVhU3N3YXlIUnd2cjhab08wMm50eEFJRHhKRXFwbUhpZWhDeGVmYndYTVlZMFVOM201ZkhQXzY5ZFptazFqMVFUbGNNZXB5ZzZ3R21vUUVGalpnVVJSeDRldWlVNUxwTg?oc=5", "source_name": "foreignpolicyjournal.com", "published_at": "2026-06-24T22:20:00+00:00", "published_display": "24 Jun 2026 22:20", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CMO Patrick Carroll sells $830,410 in stock", "summary": "Patrick Carroll, CMO of Hims & Hers Health, Inc., sold 23,726 shares of company stock for $830,410 on June 18, 2026. This transaction reduced his direct holdings to 181,861 shares of Class A Common Stock. The sale follows other company developments, including a raised price targe", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cmo-patrick-carroll-sells-830410-in-stock-93CH-4756955", "source_name": "Investing.com", "published_at": "2026-06-24T09:41:13", "published_display": "24 Jun 2026 09:41", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Hims & Hers Health, Inc. (HIMS) a Top Weight Loss Stock After Barclays\u2019 Target Increase?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijwFBVV95cUxOdGlLWTFJSThuaDJ5ZjBsVnh3c2RlNDk0czVORE1KWklybDF2UGN6eHNEWVNTTWtTNHhQOUpRdHhPdWZGM2U2YVNKM1BmazZvUUpoMTEyVVVUSzNmbl9acUhIb3hHcHAyUzJDY3FfekI4dnFBRWFjNjVmMllDZHN2RmFlc1FrbjFCSU1TbEwwSQ?oc=5", "source_name": "Market source", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Hims & Hers Health, Inc. Insider Trading Activity", "summary": "Hims & Hers Health, Inc. CFO Oluyemi Okupe reported stock option exercises and sales of common shares under a pre-arranged Rule 10b5-1 trading plan. Okupe exercised 6,376 shares of Class A common stock at $5.01 per share and sold 18,197 shares at an average price of $34.0285 per ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-215db3927dc2.html", "source_name": "Stock Titan", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CFO Oluyemi Okupe sells $619,216 in shares By Investing.com", "summary": "Hims & Hers Health, Inc.'s CFO, Oluyemi Okupe, sold 18,197 shares of Class A Common Stock for $619,216 on June 22, 2026, after exercising stock options. The sale was executed under a Rule 10b5-1 trading plan. This transaction follows other company developments, including a raised", "url": "https://ca.investing.com/news/stock-market-news/hims--hers-cfo-oluyemi-okupe-sells-619216-in-shares-93CH-4704395", "source_name": "Investing.com Canada", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CMO sells 23,726 shares, retains 181,861", "summary": "Hims & Hers Health, Inc.'s Chief Medical Officer, Patrick Harrison, sold 23,726 shares of Class A Common Stock at $35.00 per share in an open-market transaction. Following this sale, Harrison still directly holds 181,861 shares of the company. The transaction is categorized as a ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-7648d0703fd3.html", "source_name": "Stock Titan", "published_at": "2026-06-23T22:41:13", "published_display": "23 Jun 2026 22:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Expands GLP 1 Offerings With Novo Nordisk Deal And Eucalyptus Buy", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNQzEwUG1NVWZiVlg0SUgxM0dZZlgzS0lQQUhyS0VWUGlHUV9uUDQ2SVRocGpNQVk3MUUwU0F4ZUl2T2pabHdNdzVpS1ZJZ2ZzUnZtaEsxVlFVeGNmNUxESkpoMkZ2RHhqVmQyZHBVcW5MREtMNlJUSkZ3STQwdmkzUGhSOV9rT3h3XzYxVmhrVTJlQzRG?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. (HIMS) Sees a More Significant Dip Than Broader Market: Some Facts to Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOUzR4UVh4TzNkVS01RXQ1dDJDMk1tT0t6Q0J5WHFoWlRBX2pkUGd2S25xUHVHOVdrMTkyWHd6dHJ3LTVJMURaOTNsemdJQmRCbFJTcV9JT0V4cmxfYzYyR2ZsbURkeGZzdHZ0OW9IZlJZczUyRXlmTXloLUtQbzBBMWJvRy0ya0VtbXBtVWRkWl8zRHd4?oc=5", "source_name": "Market source", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Inc. Class A Trade Ideas \u2014 BIVA:HIMS", "summary": "This article compiles several trading ideas and analyses for Hims & Hers Health, Inc. (HIMS) from various traders on TradingView. It discusses potential technical patterns like inverse head and shoulders and mini head and shoulders, along with support and resistance levels, price", "url": "https://www.tradingview.com/symbols/BIVA-HIMS/ideas/page-14/", "source_name": "TradingView", "published_at": "2026-06-21T15:40:41", "published_display": "21 Jun 2026 15:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers PAO Irene Becklund sells $370,518 in stock By Investing.com", "summary": "Irene Becklund, Principal Accounting Officer at Hims & Hers Health, Inc. (NASDAQ:HIMS), sold shares totaling $370,518 in two transactions on June 16 and June 17, 2026. These sales were part of a pre-arranged trading plan and followed the vesting of Restricted Stock Units. The com", "url": "https://ng.investing.com/news/insider-trading-news/hims--hers-pao-irene-becklund-sells-370518-in-stock-93CH-2564181", "source_name": "Investing.com Nigeria", "published_at": "2026-06-18T21:10:29", "published_display": "18 Jun 2026 21:10", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) CEO exercises RSUs and withholds shares for taxes", "summary": "Hims & Hers Health CEO Andrew Dudum exercised 154,991 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations related to this vesting, 85,632 shares were withheld by the company at $30.17 per share. Following these transactions, Dudum directly holds 957,043 share", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-b76d5da84006.html", "source_name": "Stock Titan", "published_at": "2026-06-18T20:09:21", "published_display": "18 Jun 2026 20:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "HIMS (NYSE) Form 144: 12,500 and 11,226 vested Class A shares listed", "summary": "Hims & Hers Health, Inc. (HIMS) has filed a Form 144 indicating proposed sales related to the vesting of Class A shares. The filing specifies two vesting events: 12,500 shares on March 15, 2026, and 11,226 shares on June 15, 2026. Fidelity Brokerage Services LLC is named as the b", "url": "https://www.stocktitan.net/sec-filings/HIMS/144-hims-hers-health-inc-sec-filing-3ae98b82d05d.html", "source_name": "Stock Titan", "published_at": "2026-06-18T19:02:10", "published_display": "18 Jun 2026 19:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers PAO Irene Becklund sells $370,518 in stock", "summary": "Hims & Hers Health, Inc.'s Principal Accounting Officer, Irene Becklund, sold $370,518 worth of Class A Common Stock across two transactions in mid-June. These sales were executed under a pre-arranged trading plan, following the vesting of Restricted Stock Units. After these tran", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-pao-irene-becklund-sells-370518-in-stock-93CH-4748696", "source_name": "Investing.com", "published_at": "2026-06-18T09:09:39", "published_display": "18 Jun 2026 09:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers CTO Mohamed Elshenawy sells $946,260 in stock", "summary": "Hims & Hers Health, Inc. CTO Mohamed Elshenawy sold 30,040 shares of Class A Common Stock for $946,260 on June 17, 2026, as part of a Rule 10b5-1 trading plan. He also disposed of 151,534 shares worth $4,571,780 to cover tax obligations related to vested Restricted Stock Units (R", "url": "https://www.investing.com/news/insider-trading-news/hims--hers-cto-mohamed-elshenawy-sells-946260-in-stock-93CH-4748697", "source_name": "Investing.com", "published_at": "2026-06-18T08:40:00", "published_display": "18 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers COO Michael Chi sells $441,850 in company stock", "summary": "Michael Chi, COO of Hims & Hers Health, Inc., sold 14,027 shares of company stock worth $441,850 on June 17, 2026, under a pre-arranged trading plan. This sale followed his acquisition of 86,264 shares through RSU vesting, with a portion withheld for taxes. The company has also s", "url": "https://m.uk.investing.com/news/insider-trading-news/hims--hers-coo-michael-chi-sells-441850-in-company-stock-93CH-4734275?ampMode=1", "source_name": "Investing.com", "published_at": "2026-06-18T03:10:39", "published_display": "18 Jun 2026 03:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (HIMS) exec nets shares after 32,919 RSU conversion", "summary": "Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor converted 32,919 Restricted Stock Units (RSUs) into Class A Common shares on June 15, 2026. After withholding 15,396 shares for tax obligations at $30.17 per share, she now directly holds 48,961 Class A Common shares.", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-4a5e47ce0d77.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (HIMS) CMO logs RSU vesting and tax share withholding", "summary": "Hims & Hers Health Chief Medical Officer Patrick Harrison reported the vesting of 25,926 Restricted Stock Units (RSUs) on June 15, 2026. To cover tax obligations, 8,310 shares were withheld by the company, meaning no open-market sale occurred. Following these transactions, Harris", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-c1fcb1d7f2d8.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers (NYSE: HIMS) COO sells 14,027 shares, holds 432,124", "summary": "Hims & Hers Health, Inc. COO Michael Chi sold 14,027 shares of Class A Common Stock at $31.50 per share under a pre-arranged Rule 10b5-1 trading plan. This transaction followed the exercise of 86,264 RSU awards and the withholding of 47,699 shares to cover tax obligations. After ", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-2e81171f010e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) CTO exercises awards and sells 30,040 shares", "summary": "Hims & Hers Health's CTO, Mohamed Elshenawy, exercised derivative awards for 282,597 shares and sold 30,040 shares at $31.50 each under a pre-arranged Rule 10b5-1 trading plan. The company also withheld 151,534 shares to cover tax obligations from RSU vesting. Following these tra", "url": "https://www.stocktitan.net/sec-filings/HIMS/form-4-hims-hers-health-inc-insider-trading-activity-798b51647b8e.html", "source_name": "Stock Titan", "published_at": "2026-06-17T23:10:39", "published_display": "17 Jun 2026 23:10", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lead Independent Director of Hims & Hers Health David Wells Buys 27% More Shares", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims earnings today: Why Hims & Hers Health stock dropped despite raising revenue forecast - here's what i", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "The Economic Times", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Margins Worsen As Q1 Loss Resurfaces And Tests Bullish Narratives", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health (HIMS) Valuation Check After Recent Share Price Pullback", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOTWpnQnVoeGNteURwcEVKNkQ0TUNlemg1SEFRRUkwMVdrdUF3ajhIU2pweGRYaVd1S2hxaE1LdlJXV2JZVzh6MnRKVWpIM2ZHMGtMMUdncWRGMzEyYjFTeVVxeEhNdjdCWWRva21xaGhxbjRhdkFxV1pyWkt5ZUk3TGt1R3ZPLTRRcE0zSDZQaU90ZmdTd3ZvcmJ0NFI?oc=5", "source_name": "Market source", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Is Hims & Hers Health (HIMS) Stock Soaring Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPTG5UQ2d6a0xaX0YzUzNNRVJ3UmtRbUsyTjNiQ3Z1NldRbWhpSXk1cEw4QXBDUHRTNEhMUTM5cXRJYjNRd3V5NWp0RmhnM0ZfWHVEaTJXSGMyWFFLaHpvNVljOFNCRjdpM0NLY0FWREVSUFRqZ0pPSy1rMkZrTDloWlY4YkhZTENvaU5VWExNamhvT3kx?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Hims & Hers Health (HIMS) Pricing Reflect Fast-Growing Telehealth Hype Or Business Fundamentals", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Health Insurance Providers Stocks\u2019 Q4 Earnings: Alignment Healthcare (NASDAQ:ALHC) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNT01mVGxMZ0dTU1BFZll2Wm5Bekc1STJkajdhWGFYMmJGUktiVFZGN2k4b3ZobDNVbW5IejF6dGZYWERRR1g0aHhrcUJnZ09PeU1sb3FISTZjWjlVMmFMMEhVdERvU0k0a2tIQmhkSTB4bzFaN1NYbi1xekk1OHk5TE82WlpkVmVHZ2VNY25OejQ2MHhsRVNsbngydG5Rd29TcmJuLVI3YlU?oc=5", "source_name": "Market source", "published_at": "2026-04-03T07:00:00+00:00", "published_display": "03 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health, Regeneron, Biogen, BioMarin Pharmaceutical, and Moderna Shares Are Falling, What You Need To Know", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxQenJ0SlI0Qi1FWUlBa2ZIdm5ZN0piTkpwS1p6VWlTeE5aVGdRMHJnRTUtdzh2ZXhkNWhEdUtJMUxDS2oyOFZQeXJVT1RSVU9sRWhjaWJBVmxKUnZ4cm85ZS05WnNXZDYxVVNuSWJNM1RucVZxUkFiXzRSZWNCaDJQZk56LVhteGpBNDZYdXpLS043amZkcG5nRjZoUEw3Qk9xU0xMTHN2VzdqamV1SU10cUJtc3N5NWNISi1mem9fYTQxX0NTMlpKdW01dFdpRHJvWDRtUzNhU1U1N3JqUHZENzhYZkdnMlBmeHVsNGdMa29icmF6UnlRQnVXX1haY3N2?oc=5", "source_name": "TradingView", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hims & Hers Health to acquire Australia's Eucalyptus for up to $1.15 billion", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxNOEQ3d0FVcEtzdXpCSlBaSGhzT1FrNlhtWm5qQ2loWjVjTkdmckNJcktybXd3Y0hiZENOaGRYSzNvM2JmSHVzdkdYSGxaWS1nNWh0NDI5Z3dzZV92bVJwMTkyTEZzcWhQb2pmUG9KWVhrMmczaFpaRklmYVlQLVlVRVhVZXhQN1JXNkdjUU85dDBXQ045aEVzYXI0LVFYX292cE1HbEVIVEpteWNvNV9ZU21wNno?oc=5", "source_name": "Reuters", "published_at": "2026-02-19T08:00:00+00:00", "published_display": "19 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "The Price Is Right For Hims & Hers Health, Inc. (NYSE:HIMS) Even After Diving 46%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-02-11T08:00:00+00:00", "published_display": "11 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 97, "total_relevant": 52, "sentiment_summary": {"positive": 6, "negative": 11, "neutral": 35, "score": 48, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 86, "events": [{"event": "general", "label": "Market update", "weight": 22.85, "count": 39}, {"event": "earnings", "label": "Earnings", "weight": 2.55, "count": 4}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.65, "count": 3}, {"event": "deals", "label": "Deals and strategy", "weight": 1.1, "count": 2}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 11}, "market_context": {"has_market_context": true, "latest_close": 34.38, "latest_week": "2026-07-10", "one_week_move": -6.6, "four_week_move": 28.2, "twelve_week_move": 19.3, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.316296, "market_dynamics_buy_signal": false, "relative_strength": -14.051045, "fair_value_gap": 30.5, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "undecided", "expectation_probability": 49.5096, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-6.6% over one week, +28.2% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "negative", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 10}, {"label": "simplywall.st", "count": 7}, {"label": "Market source", "count": 7}, {"label": "Investing.com", "count": 5}, {"label": "TradingView", "count": 5}, {"label": "Zacks", "count": 3}, {"label": "The National Law Review", "count": 3}, {"label": "Stock Traders Daily", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 52}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 39}, {"label": "Earnings", "count": 4}, {"label": "Analyst action", "count": 3}, {"label": "Regulatory and legal", "count": 3}, {"label": "Deals and strategy", "count": 2}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "48/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "negative", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "86/100 classification confidence."}, {"label": "Company focus", "value": "52", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "5", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-6.6% over one week, +28.2% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Hims & Hers Health Jumps 6.2% After B of A Securities Maintains Neutral"}], "updated_at": "2026-07-16T11:43:17.333043+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}